Subscribe
Webinars
White Papers
Buyer's Guide
PhotonicsNXT
Get Published!
Lasers/Sources
Detectors/Imaging
Optics
Bio & Life Sciences
Laser Processing
Test/Measurement
Science & Research
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
LFW Photonics Market Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Recursion Pharmaceuticals Inc Cl A
(NQ:
RXRX
)
7.610
-0.280 (-3.55%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 27, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Recursion Pharmaceuticals Inc Cl A
< Previous
1
2
3
4
5
6
7
8
9
10
11
Next >
Why Clover Health Investments Shares Are Trading Higher By 11%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
March 13, 2024
Shares of Clover Health Investments, Corp. (NASDAQ: CLOV) rose sharply during Wednesday’s session after the company reported better-than-expected fourth-quarter revenue results and issued FY24...
Via
Benzinga
Nvidia's Secret Weapon Is Not Just Chips But Investing $1.5B In AI's Rising Stars: Report Unveils CEO Jensen Huang's 10-Year Vision
March 11, 2024
Additionally, the investments help Nvidia "build out the future ecosystem of businesses that depend on its technology" even as rivals are trying to break into the chipmaker's dominance.
Via
Benzinga
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Recursion Pharmaceuticals Stock Has 33% Upside, According to 1 Wall Street Analyst
March 07, 2024
The company just made a provocative move in one of its collaborations.
Via
The Motley Fool
Forecasting The Future: 4 Analyst Projections For Recursion Pharmaceuticals
March 04, 2024
Via
Benzinga
Earnings Scheduled For February 27, 2024
February 27, 2024
Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report quarterly loss at $0.07 per share on revenue of $100.49 million.
Via
Benzinga
The Top 7 Small-Cap Stocks to Buy in March 2024
March 04, 2024
These top small-cap stocks to buy are set for a strong 2024 as reduced inflation increases their growth prospects.
Via
InvestorPlace
Topics
Economy
Exposures
Interest Rates
The Top 3 Healthcare Stocks to Buy on Weakness in 2024
March 04, 2024
Many healthcare stocks have extremely bright outlooks and very low valuations. Here are three top healthcare stocks to buy.
Via
InvestorPlace
AI-Powered Drug Discovery Stocks Index Up 9% In February; Remains Down 8% YTD
March 04, 2024
Grand View Research says the global
Via
Talk Markets
Cathie Wood Just Bought These 3 Biotech Stocks. Should You Buy, Too?
March 01, 2024
On the leading edge of rare disease treatment and therapy is where you will find these Cathie Wood biotech stocks.
Via
InvestorPlace
Why Recursion Pharmaceuticals Stock Dived by Nearly 17% Today
February 28, 2024
The company had attracted much interest due to its heavy use of artificial intelligence, but its latest fundamentals disappointed many.
Via
The Motley Fool
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Why Bumble Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
February 28, 2024
Shares of Bumble Inc. (NASDAQ: BMBL) fell sharply during Wednesday’s session following weak quarterly results.
Via
Benzinga
Why Beyond Meat Shares Are Trading Higher By Around 56%; Here Are 20 Stocks Moving Premarket
February 28, 2024
Shares of Beyond Meat, Inc. (NASDAQ: BYND) rose sharply in today’s pre-market trading as the company reported stronger-than-expected sales for its fourth quarter.
Via
Benzinga
3D Systems Posts Downbeat Q4 Results, Joins Eventbrite, Lemonade And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
February 28, 2024
U.S. stock futures were lower this morning, with the Dow futures trading lower by around 100 points on Wednesday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
What's Going On With Recursion Pharmaceuticals Stock Tuesday?
February 27, 2024
Recursion reported fourth-quarter revenue of $10.89 million, which missed the consensus estimate of $20.35 million. The clinical stage biotech company reported a quarterly loss of 42 cents per share,...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
February 27, 2024
Via
Benzinga
10+ Stocks, ETFs To Ride On Nvidia's Record-Breaking Success
February 22, 2024
Shares of NVIDIA Corp rose 15% as quarterly earnings beat forecasts. CEO cites AI's role in company's growth. Tech sector up. ETFs benefit.
Via
Benzinga
Topics
Artificial Intelligence
ETFs
Earnings
Exposures
Artificial Intelligence
Financial
Why Etsy Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
February 22, 2024
Shares of Etsy, Inc.
Via
Benzinga
These 2 Healthcare Stocks Are in Nvidia's Portfolio. Should They Be in Yours?
February 22, 2024
These companies are focused on next-gen technologies that could help transform the healthcare industry.
Via
The Motley Fool
NVIDIA Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
February 21, 2024
NVIDIA Corporation (NASDAQ: NVDA) is expected to release earnings results for its fourth quarter, after the closing bell on Feb. 21, 2024.
Via
Benzinga
Nvidia Just Invested in These 5 Artificial Intelligence (AI) Stocks. Here's the Best of the Bunch.
February 21, 2024
See which AI stocks the world's hottest AI chipmaker especially likes.
Via
The Motley Fool
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Why Did Nvidia Invest in These 5 Artificial Intelligence (AI) Stocks? Should You Buy Them, Too?
February 20, 2024
Nvidia's 13F revealed some interesting investments.
Via
The Motley Fool
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Investors Are Piling Into Nvidia Stock. But Nvidia Is Investing in 5 Other AI Stocks.
February 19, 2024
Two of these stocks represent some of the best potential applications for AI technology.
Via
The Motley Fool
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
AI-Powered Drug Discovery Stocks Index Up 18% Last Week, Led By BioXcel Therapeutics
February 19, 2024
The AI-powered drug discovery market is projected to grow at a 30% CAGR between now and 2030, with annual sales in excess of $50 billion anticipated. An AI drug discovery revolution is underway.
Via
Talk Markets
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Get Rich Quick With These 3 AI Stocks to Buy Now
February 18, 2024
Jump on the AI revolution with three AI stocks poised for rapid growth. Don't miss out on these potential wealth generators in the tech boom.
Via
InvestorPlace
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Nvidia Has Invested in Arm Holdings and a Few Other Artificial Intelligence (AI) Stocks -- Should Investors Follow?
February 16, 2024
Nvidia released its 13F for the first time and caused numerous stocks to skyrocket.
Via
The Motley Fool
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Why Recursion Pharmaceuticals Stock Zoomed Higher on Thursday
February 15, 2024
A top name in the artificial intelligence world has put its money where its mouth is with this biotech.
Via
The Motley Fool
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
The 3 Up-and-Coming Stocks That Could Make Your February Unforgettable
February 15, 2024
Finding an up-and-coming stock worth investing in is harder than it used to be, but you don't have to look far if you check out this list.
Via
InvestorPlace
5 Stocks to Buy to Invest Like Nvidia
February 15, 2024
Do you want to invest like Nvidia? Here are the stocks to buy if you want to follow the chipmaker's methodology and focus on AI exposure.
Via
InvestorPlace
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
3 AI Stocks that Could be the Next Palantir
February 15, 2024
These niche AI stocks are using Palantir's ascent as a roadmap to market dominance in their respective fields.
Via
InvestorPlace
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Nvidia Is Betting on SoundHound AI (SOUN) Stock
February 15, 2024
SOUN stock has been having a great last month, and a disclosure showing that Nvidia is betting on it, too, is sending SOUN even higher.
Via
InvestorPlace
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
< Previous
1
2
3
4
5
6
7
8
9
10
11
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.